Literature DB >> 29152486

Avatars to personalized medicine: of mice and men.

Matthias Ilmer1, Michael Berger2,3.   

Abstract

Entities:  

Year:  2017        PMID： 29152486      PMCID： PMC5673770          DOI： 10.21037/hbsn.2017.06.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  9 in total

1.  Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.

Authors:  Ferdinand Wagner; Bente Henningsen; Christine Lederer; Melanie Eichenmüller; Jan Gödeke; Josef Müller-Höcker; Dietrich von Schweinitz; Roland Kappler
Journal:  Eur J Cancer       Date:  2012-01-28       Impact factor: 9.162

2.  Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.

Authors:  Matthias Ilmer; Agnès Garnier; Jody Vykoukal; Eckhard Alt; Dietrich von Schweinitz; Roland Kappler; Michael Berger
Journal:  Mol Cancer Ther       Date:  2015-10-29       Impact factor: 6.261

3.  Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.

Authors:  Michael Berger; Olaf Neth; Matthias Ilmer; Agnès Garnier; Manuel Vicente Salinas-Martín; Juan Carlos de Agustín Asencio; Dietrich von Schweinitz; Roland Kappler; Miguel Muñoz
Journal:  J Hepatol       Date:  2014-01-08       Impact factor: 25.083

4.  Somatic mutations of the APC gene in sporadic hepatoblastomas.

Authors:  H Oda; Y Imai; Y Nakatsuru; J Hata; T Ishikawa
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

5.  The genomic landscape of hepatoblastoma and their progenies with HCC-like features.

Authors:  Melanie Eichenmüller; Franziska Trippel; Michaela Kreuder; Alexander Beck; Thomas Schwarzmayr; Beate Häberle; Stefano Cairo; Ivo Leuschner; Dietrich von Schweinitz; Tim M Strom; Roland Kappler
Journal:  J Hepatol       Date:  2014-08-15       Impact factor: 25.083

6.  Blocking the hedgehog pathway inhibits hepatoblastoma growth.

Authors:  Melanie Eichenmüller; Ivonne Gruner; Beate Hagl; Beate Häberle; Josef Müller-Höcker; Dietrich von Schweinitz; Roland Kappler
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Authors:  Ken Taniguchi; Lewis R Roberts; Ileana N Aderca; Xiangyang Dong; Chiping Qian; Linda M Murphy; David M Nagorney; Lawrence J Burgart; Patrick C Roche; David I Smith; Julie A Ross; Wanguo Liu
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

8.  Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.

Authors:  A Koch; D Denkhaus; S Albrecht; I Leuschner; D von Schweinitz; T Pietsch
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

9.  Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.

Authors:  Stefano Cairo; Carolina Armengol; Aurélien De Reyniès; Yu Wei; Emilie Thomas; Claire-Angélique Renard; Andrei Goga; Asha Balakrishnan; Michaela Semeraro; Lionel Gresh; Marco Pontoglio; Hélène Strick-Marchand; Florence Levillayer; Yann Nouet; David Rickman; Frédéric Gauthier; Sophie Branchereau; Laurence Brugières; Véronique Laithier; Raymonde Bouvier; Françoise Boman; Giuseppe Basso; Jean-François Michiels; Paul Hofman; Francine Arbez-Gindre; Hélène Jouan; Marie-Christine Rousselet-Chapeau; Dominique Berrebi; Luc Marcellin; François Plenat; Dominique Zachar; Madeleine Joubert; Janick Selves; Dominique Pasquier; Paulette Bioulac-Sage; Michael Grotzer; Margaret Childs; Monique Fabre; Marie-Annick Buendia
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743
  9 in total
  1 in total

Review 1.  Humanized mice for immune checkpoint blockade in human solid tumors.

Authors:  Henry Yip; Carl Haupt; Grace Maresh; Xin Zhang; Li Li
Journal:  Am J Clin Exp Urol       Date:  2019-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.